Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dexrazoxane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A known ✓ | P11388 | 3/20 | 0.83 |
| ▸ | TOP2B known ✓ | Q02880 | 3/20 | 0.83 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.83 |
| ▸ | LMNA | P02545 | 1/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dexrazoxane SCHEMBL18400 | 0.91 | TOP2A (1.00) | TOP2ATOP2BPTGS1LMNAALDH1A1 | |
| Dexrazoxane SCHEMBL1586271 | 0.91 | TOP2A (1.00) | TOP2ATOP2BPTGS1LMNAALDH1A1 | |
| Dexrazoxane SCHEMBL18188 | 0.90 | TOP2A (0.96) | TOP2ATOP2BPTGS1LMNAALDH1A1 | |
| Dexrazoxane SCHEMBL5295434 | 0.87 | TOP2A (0.83) | TOP2ATOP2BPTGS1LMNAALDH1A1 | |
| SCHEMBL21473070 | 0.82 | TOP2A (0.81) | TOP2ATOP2BPTGS1LMNAALDH1A1 | |
| SCHEMBL14006928 | 0.80 | TOP2A (0.77) | TOP2ATOP2BPTGS1LMNAALDH1A1 | |
| SCHEMBL14006975 | 0.80 | TOP2A (0.77) | TOP2ATOP2BPTGS1LMNAALDH1A1 | |
| SCHEMBL17471506 | 0.80 | TOP2A (0.77) | TOP2ATOP2BPTGS1LMNAALDH1A1 | |
| SCHEMBL14006924 | 0.80 | TOP2A (0.77) | TOP2ATOP2BPTGS1LMNAALDH1A1 | |
| SCHEMBL11929245 | 0.80 | TOP2A (0.77) | TOP2ATOP2BPTGS1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007062076-A2 | DEXRAZOXANE FORMULATIONS AND METHODS | NOVARTIS AG (CH) | 2007-05-31 | — | — | WO | disclosed |